Pentoxifylline

  • TRADE NAMES: Apo-Pentoxifylline; Artal; Azupentat; Elorgan; Hemovas; Pentoxi; Pentoxil (Upsher-Smith); Pexal; Torental; Trental (Sanofi-Aventis)
  • INDICATIONS: Peripheral vascular disease, intermittent claudication
  • CLASS: Vasodilator, peripheral, Xanthine alkaloid
  • HALF-LIFE: 0.4–0.8 hours

Our database has 22 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top